Bracco Celebrates Personalized and Precision Medicine Innovations

At RSNA 2021, Bracco Diagnostics is featuring its full array of diagnostic imaging products including, Iodinated, MR, Ultrasound and Barium contrast agents, their portfolio of delivery systems, informatics and much more that are propelling personalized and precision medicine forward, while demonstrating understanding of the community’s needs today.

“Customers can expect to see a patient-focused approach to diagnostic imaging, something which has been a longtime focus for our company said Cosimo DePinto, Senior Vice President, Sales and Marketing at Bracco Diagnostics. “As usual, the RSNA allows us to feature all that we offer. Additionally, it’s an excellent opportunity to connect with our customers and support the industry at-large.”

Since RSNA 2020, Bracco has reached several milestones to help advance personalized, value-based care for radiology. First, the company secured two US Food and Drug Administration (FDA) approvals, one aiming to help the youngest patients, and the other to increase efficiencies and reduce waste.

The company established a key partnership aimed at improving patient access to cardiac positron emission tomography (PET) imaging in more diverse patient care sites, including at the community level. The company also sponsored a new mentorship program with a renowned imaging society aimed at supporting the academic and professional development of imaging professionals throughout their careers.

“We bring a personal approach to customer relationships, all focused on enhancing workflows, boosting productivity and promoting patient-centric care” said De Pinto. “It’s a partnership, and at our booth customers can see the people they know, trust and depend on for their diagnostic imaging needs.”

RSNA Booth: South 1129